amoebic gill disease
Epidemiology of amoebic gill disease
181
Role of bacteria in amoebic gill disease
165
Immune regulatory genes in amoebic gill disease : potential for immunomodulation
195
Cyclic hypoxia exposure accelerates the progression of amoebic gill disease
14
Pathology of amoebic gill disease in Atlantic Salmon (Salmo salar L )
195
Concentration effects of Winogradskyella sp. on the incidence and severity of amoebic gill disease
5
Oral treatment for amoebic gill disease (AGD) in Atlantic salmon, Salmo salar
181
The aetiology of amoebic gill disease (AGD) and aspects of the host immune response to infection
274
Assessment of resistance to amoebic gill disease in the Tasmanian Atlantic salmon selective breeding population
195
Genome-Wide Association and Genomic Selection for Resistance to Amoebic Gill Disease in Atlantic Salmon
32
Host response to amoebic gill disease in Atlantic salmon and blood fluke infection in Pacific bluefin tuna
150
Risk assessment of amoebic gill disease Opinion of the Panel on Animal Health and Welfare of the Norwegian Scientific Committee for Food Safety
40
Surface environment modification in Atlantic salmon sea-cages: Effects on amoebic gill disease, salmon lice, growth and welfare
11
Using the mucosal response to recombinant Neoparamoeba perurans attachment proteins to design an experimental vaccine against amoebic gill disease (AGD)
32
Using the mucosal response to recombinant Neoparamoeba perurans attachment proteins to design an experimental vaccine against amoebic gill disease (AGD)
234
Bath treatment of Atlantic salmon (Salmo salar) with amoebae antigens fails to affect survival to subsequent amoebic gill disease (AGD) challenge
6
Molecular assessment of resistance to amoebic gill disease
263
Potential risk factors of amoebic gill disease in Tasmanian Atlantic salmon
136
Geographic characterization and environmental detection of Neoparamoeba perurans the causative agent of amoebic gill disease
241
Amoebic gill disease of Atlantic salmon : resistance, serum antibody response and factors that may influence disease severity
228